CDC25C Protein
Overview
CDC25C (cell division cycle 25 homolog C) is a serine/threonine protein phosphatase that plays a critical regulatory role in cell cycle control and stress response pathways. As a member of the CDC25 phosphatase family, CDC25C is highly conserved across eukaryotic organisms and functions as a key checkpoint regulator. The protein is encoded by the CDC25C gene located on human chromosome 5q31. In neurons and other non-dividing cells, CDC25C maintains additional functions beyond classical cell cycle regulation, including roles in cytoskeletal dynamics, synaptic plasticity, and stress-induced cell death pathways that are particularly relevant to neurodegenerative processes.
Function/Biology
CDC25C functions primarily as a dual-specificity phosphatase, capable of removing phosphate groups from both serine/threonine and tyrosine residues on target proteins. Its canonical role involves dephosphorylation of CDK1 (cyclin-dependent kinase 1, also called cdc2), which activates this kinase and promotes G2/M phase transition in dividing cells. This function is tightly regulated through multiple mechanisms: CDC25C itself is phosphorylated by checkpoint kinases (CHK1 and CHK2) during DNA damage responses, leading to its cytoplasmic sequestration and inactivation by binding to 14-3-3 proteins.
...CDC25C Protein
Overview
CDC25C (cell division cycle 25 homolog C) is a serine/threonine protein phosphatase that plays a critical regulatory role in cell cycle control and stress response pathways. As a member of the CDC25 phosphatase family, CDC25C is highly conserved across eukaryotic organisms and functions as a key checkpoint regulator. The protein is encoded by the CDC25C gene located on human chromosome 5q31. In neurons and other non-dividing cells, CDC25C maintains additional functions beyond classical cell cycle regulation, including roles in cytoskeletal dynamics, synaptic plasticity, and stress-induced cell death pathways that are particularly relevant to neurodegenerative processes.
Function/Biology
CDC25C functions primarily as a dual-specificity phosphatase, capable of removing phosphate groups from both serine/threonine and tyrosine residues on target proteins. Its canonical role involves dephosphorylation of CDK1 (cyclin-dependent kinase 1, also called cdc2), which activates this kinase and promotes G2/M phase transition in dividing cells. This function is tightly regulated through multiple mechanisms: CDC25C itself is phosphorylated by checkpoint kinases (CHK1 and CHK2) during DNA damage responses, leading to its cytoplasmic sequestration and inactivation by binding to 14-3-3 proteins.
In addition to CDK1 regulation, CDC25C interacts with diverse cellular substrates including p38 mitogen-activated protein kinase (MAPK), CDK5, and various components of the Wnt/β-catenin signaling pathway. These interactions enable CDC25C to influence processes beyond cell division, including stress responses, gene transcription, and cell morphology changes. The protein contains a conserved catalytic domain with a distinctive active site pocket and regulatory domains that allow for phosphorylation-dependent modulation of its activity and subcellular localization.
Role in Neurodegeneration
CDC25C has emerged as a significant player in multiple neurodegenerative pathways. In Alzheimer's disease, aberrant CDC25C activity has been associated with abnormal tau phosphorylation and the formation of neurofibrillary tangles. The dysregulation of CDC25C-mediated dephosphorylation of CDK5 substrates may contribute to tau hyperphosphorylation, a hallmark pathological feature. Furthermore, CDC25C has been implicated in neuronal apoptosis pathways activated during neurodegeneration, where its activity influences pro-death signaling cascades.
In Parkinson's disease models, CDC25C dysfunction has been observed in response to oxidative stress and mitochondrial dysfunction, conditions central to dopaminergic neuronal loss. Additionally, CDC25C activity may influence α-synuclein aggregation and clearance through its effects on cellular stress response pathways and protein quality control mechanisms.
Molecular Mechanisms
The molecular mechanisms linking CDC25C to neurodegeneration involve several interconnected pathways. During cellular stress, CDC25C undergoes phosphorylation by stress-activated kinases, particularly CHK1 and CHK2, which disrupts its normal catalytic function and promotes its sequestration away from substrates. This stress-induced inactivation can paradoxically promote apoptosis by preventing the dephosphorylation and inactivation of pro-apoptotic kinases.
CDC25C also regulates CDK5, an atypical kinase highly active in neurons that phosphorylates tau and other cytoskeletal proteins. Dysregulation of this CDC25C-CDK5 axis directly impacts tau phosphorylation patterns. Additionally, CDC25C interacts with components of the ubiquitin-proteasome system and autophagy-related proteins, influencing protein aggregation and clearance—processes critical for preventing accumulation of misfolded proteins characteristic of neurodegenerative diseases.
Clinical/Research Significance
Research into CDC25C holds promise for understanding disease mechanisms and developing therapeutic interventions. CDC25C inhibitors and modulators are being explored in cancer research and have potential applications in neurodegenerative disease models. Pharmacological modulation of CDC25C activity could potentially reduce neuronal apoptosis or improve protein quality control in degenerating neurons.
Biomarker studies investigating CDC25C phosphorylation patterns in cerebrospinal fluid and neuronal tissue from neurodegenerative disease patients may provide diagnostic or prognostic value. Understanding CDC25C regulation in disease-relevant contexts could inform development of neuroprotective strategies.
- CDC25A, CDC25B (other CDC25 family members)
- CDK1, CDK5 (primary substrates)
- CHK1, CHK2 (regulatory kinases)
- Tau protein, neurofibrillary tangles
- α-synuclein aggregation
- 14-3-3 proteins (regulatory binding partners)
- p38 MAPK signaling pathway